H00010801-M01
antibody from Novus Biologicals
Targeting: SEPTIN9
AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00010801-M01 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00010801-M01, RRID:AB_922413
- Product name
- Mouse Monoclonal Septin-9 Antibody
- Antibody type
- Monoclonal
- Description
- IgG purified. SEPT9 - septin 9 (2C6)
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references A SEPT1-based scaffold is required for Golgi integrity and function.
SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR.
Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
Song K, Gras C, Capin G, Gimber N, Lehmann M, Mohd S, Puchkov D, Rödiger M, Wilhelmi I, Daumke O, Schmoranzer J, Schürmann A, Krauss M
Journal of cell science 2019 Feb 1;132(3)
Journal of cell science 2019 Feb 1;132(3)
SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR.
Diesenberg K, Beerbaum M, Fink U, Schmieder P, Krauss M
Journal of cell science 2015 Jan 15;128(2):397-407
Journal of cell science 2015 Jan 15;128(2):397-407
Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR
Cancer research 2010 May 1;70(9):3780-90
Cancer research 2010 May 1;70(9):3780-90
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- ELISA: Septin-9 Antibody (2C6) [H00010801-M01] - Detection limit for recombinant GST tagged SEPT9 is 0.03 ng/ml as a capture antibody.